Cite
APA Citation
Xu, Z., Yi, F., Yu, D., Xu, J., Wei, Y., & Zhang, W. (n.d.). nivolumab provides improved effectiveness and safety compared with docetaxel as a second‐line treatment for advanced non‐small cell lung cancer: A systematic review and meta‐analysis. Cancer medicine, 8, 629–642. http://access.bl.uk/ark:/81055/vdc_100084507822.0x000009